Kidney fibrosis is a final common pathogenic process for many forms of chronic renal disease, including HIV-associated nephropathy (HIVAN), which is a leading cause of renal disease among HIVinfected African Americans 1 . Collapsing focal segmental glomerulosclerosis (FSGS), tubulointerstitial inflammation and fibrosis, tubular dilatation with microcyst formation and renal tubular epithelial cell (RTEC) apoptosis are key pathologic features of HIVAN 2 . HIV directly infects RTECs, but the cellular response to HIV infection is not well defined 3 . An HIV transgenic mouse model (Tg26), which has the proviral transgene pNL4-3: d1443 encoding all the HIV genes except gag and pol, recapitulates the renal pathologic changes observed in human disease and has been used to study HIVAN pathogenesis 4, 5 . Although prior studies have identified individual protein regulators, protein-protein interactions and cell signaling pathways that are altered in HIVAN, a systematic evaluation of these changes has not been attempted.
Transcriptomic measurements are reflective of quantitative changes in mRNA levels but do not provide a direct understanding of the upstream regulatory mechanisms that are responsible for observed changes in gene expression. Identifying potential regulatory mechanisms responsible for changes in gene expression under disease conditions could help to reveal disease mechanisms and enable the discovery of drug targets. Here we present an integrative experimental and computational approach for identifying and ranking protein kinases that are probably responsible for the observed changes in mRNA expression and transcription-factor activation. We computationally predicted that HIPK2 is crucially involved in HIVAN.
HIPK2 is a conserved serine/threonine nuclear kinase that regulates gene expression by phosphorylating transcription factors and accessory components of the transcriptional machinery 6 . HIPK2 is activated in response to morphogenic signals that regulate cell differentiation and apoptosis in neurons 7 . In response to DNA-damaging agents, HIPK2 promotes apoptosis by phosphorylating and activating p53 (ref. 8) . HIPK2 also mediates the activation of Wnt 9 , Notch 10 and TGF-β-induced signaling 11, 12 . Because p53 and TGF-β are known mediators of apoptosis for RTECs [13] [14] [15] and the TGF-β, Notch and Wnt-β-catenin pathways promote renal fibrosis [16] [17] [18] [19] , we hypothesized and experimentally validated that HIPK2, a previously unrecognized kinase in the context of kidney disease, contributes to kidney epithelial cell injury and renal fibrosis in HIVAN and other animal models of renal tubular injury.
RESULTS

HIPK2 is a potential mediator of HIVAN pathogenesis
We confirmed the renal histopathology ( Supplementary Table 1 ) and determined genes differentially expressed in the kidney cortices of Tg26 mice compared to matched wild-type (WT) littermates; 434 genes were significantly upregulated and 72 genes were significantly downregulated in Tg26 mice compared to WT mice (t test with false discovery rate P < 0.01). We computationally deduced the upstream transcription factors probably responsible for the observed changes in gene expression using two methods. First, we used TRANSFAC matrices 20 to scan the promoter region of genes to identify transcription factors with overrepresented binding sites among the 434 upregulated genes. Using this approach, we identified nine transcription factors (Supplementary Data). However, we identified only one transcription factor when we applied the same approach to the 72 downregulated genes. Thus, we used only the upregulated genes in our subsequent analyses. We used a second computational approach (chromatin immunoprecipitation (ChIP) Enrichment Analysis (ChEA) 21 ) to identify upstream transcription factors and found a total of 62 (Supplementary Data). We experimentally profiled protein-DNA interactions that were differentially regulated between Tg26 and WT kidneys using a protein-DNA binding array ( Fig. 1 and Supplementary Fig. 1a ). We identified 12 upregulated and 14 downregulated binding interactions for 35 transcription factors ( Supplementary Table 2 and Supplementary Data). Some consensus binding motifs on the protein-DNA array were linked to several transcription factors. We confirmed the activity of the selected transcription factors by electrophoretic mobility shift assay ( Supplementary Fig. 1b ). We generated a list of selectively combined transcription factors by including the top five transcription factors from the TRANSFAC analysis and the top five transcription factors from ChEA, as well as transcription factors that were predicted by either TRANSFAC or ChEA and also identified by the protein-DNA interaction array-three for TRANSFAC with the protein-DNA interaction array and five for ChEA with the protein-DNA interaction array-without any overlapping ( Fig. 1 and Supplementary Data) . These 18 transcription factors are potentially responsible for the pattern of gene expression in the Tg26 kidney.
We linked these transcription factors to upstream regulatory mechanisms by constructing a protein-protein interaction subnetwork based on known interactions (Genes2Networks) 22 . This subnetwork has 205 nodes and was enriched in co-regulators and other transcription factors that physically interact with the 18 transcription factors identified above ( Fig. 1 and Supplementary Data) . We further linked protein kinases that probably phosphorylate proteins within the subnetwork using Kinase Enrichment Analysis (KEA) 23 . Consistent with our previous studies 24 , mitogen-activated protein kinase 3 (MAPK3) and MAPK1 (the canonical MAP kinases ERK1 and ERK2) were highly ranked, whereas the lesser-known kinase HIPK2 was third on the list (Fig. 1) . HIPK2 has 14 substrates within the subnetwork, which is almost half of all the known substrates for HIPK2 (n = 34 total substrates, P = 2.2 × 10 −9 ; Supplementary Data).
HIV promotes HIPK2 expression in kidney cells
We examined the expression of HIPK2 in Tg26 kidneys. Immunostaining of HIPK2 revealed that its expression was higher mostly in the tubular compartment and only mildly in glomeruli of Tg26 mice compared to WT mice ( Fig. 2a ). This was confirmed by a western blot analysis of protein lysates from the renal cortex, which contains mostly tubules, and of isolated glomeruli (Fig. 2b) . The expression of HIPK2 mRNA in the renal cortex and in isolated glomeruli was not statistically different between Tg26 and WT mice ( Fig. 2c ), suggesting that HIPK2 protein expression was regulated at the posttranslational level. We observed a corresponding higher amount of HIPK2 kinase activity in Tg26 kidneys than WT kidneys (Fig. 2d) . The amount of HIPK1 and HIPK3 was not different between Tg26 and WT kidneys (data not shown).
To examine whether HIV infection of kidney cells was responsible for the induction of HIPK2 activity, we infected primary human renal tubular epithelial cells (hRTECs) with pseudotyped HIV virions that contained the HIV gag/pol-deleted pNL4-3:d1443 proviral DNA. HIPK2 protein expression increased but mRNA levels were unchanged in these cells after infection with HIV ( Fig. 2e,f ). HIPK2 kinase activity was increased by HIV infection, and expression of a kinase-dead mutant of HIPK2 (KD-HIPK2) in HIV-infected cells suppressed any HIV-induced increase in HIPK2 kinase activity ( Fig. 2g) .
To examine the post-translational regulation of HIPK2 by proteasomal degradation, we treated cells with MG132, which is a specific 26S proteosome inhibitor, and found that HIPK2 expression was significantly increased as a result of this treatment ( Fig. 2h) , which suggests that HIV infection increased HIPK2 activity by reducing HIPK2 proteasomal degradation.
SIAH1 is an upstream regulator of HIPK2
Next, we determined how HIV upregulates HIPK2 protein concentrations. DNA damage increases HIPK2 protein concentrations by inhibiting the ubiquitin ligase SIAH1, which facilitates HIPK2 polyubiquitination and proteasomal degradation 25 . HIV infection promotes oxidative stress 26 and DNA damage 27 in kidney cells. As SIAH1 expression was reduced in our gene expression microarray data from the Tg26 renal cortex, we sought to examine whether HIV-induced upregulation of HIPK2 was a result of a reduction in SIAH1 concentrations.
We first confirmed that SIAH1 expression was diminished in the Tg26 renal cortex using real-time PCR ( Fig. 3a) Figure 1 Identification of key signaling pathways activated in HIVAN. Two methods of computational promoter analysis (TRANSFAC and ChEA) and a protein-DNA interaction array were used to identify 18 transcription factors (TFs) differentially activated in kidneys of Tg26 mice. The top five ranked transcription factors from each of the promoter analyses are shown in blue; transcription factors that are in common between TRANSFAC and the protein-DNA interaction array are shown in yellow; and transcription factors that are in common between ChEA and the protein-DNA interaction array are shown in orange. We generated a subnetwork of proteins that interacted with this selectively combined list of 18 transcription factors using Genes2Networks. Proteins within the subnetwork (n = 205) were used as inputs for KEA to identify protein kinases that are probably responsible for the phosphorylation of proteins within the subnetwork. HIPK2 is the third most highly ranked kinase (shown in red). PPI, protein-protein interaction.
npg blot ( Fig. 3b) . We observed an inverse relationship between the protein concentrations of SIAH1 and HIPK2 by western blot (Fig. 3b ) and by immunostaining in adjacent kidney sections (Fig. 3c) . The weak background staining seen in Figure 3c is likely a result of the short development of the stain. Next, we determined whether HIV infection reduces SIAH1 expression. We found that infection of hRTECs by HIV suppressed SIAH1 protein and SIAH1 mRNA expression ( Fig. 3d,e ).
To confirm the role of SIAH1 in the regulation of HIPK2, we either overexpressed or silenced SIAH1 in hRTECs by transfecting a SIAH1 expression construct or a specific siRNA, respectively (see Supplementary Fig. 1c -e for the efficiency of the transfections). HIPK2 protein concentration was increased by SIAH1 knockdown and was reduced by SIAH1 overexpression (Fig. 3f) , indicating that SIAH1 acts upstream of HIPK2. To determine the mechanisms by which HIV infection suppressed SIAH1 expression, we treated hRTECs with H 2 O 2 and adriamycin and found that both treatments reduced SIAH1 and increased HIPK2 expression ( Fig. 3g,h) . Pretreatment with an oxidant scavenger, N-acetylcysteine (NAC), abrogated HIV-induced HIPK2 upregulation and restored SIAH1 expression in the hRTECs (Fig. 3i) . Treatment with either H 2 O 2 or adriamycin did not affect the level of HIPK2 mRNA in the hRTECs (data not shown).
Expression of SIAH1 and HIPK2 in human kidneys
We corroborated the in vitro findings by examining the renal expression of SIAH1 and HIPK2 in different kidney diseases. HIPK2 nuclear staining was markedly higher in kidneys of patients with HIVAN, FSGS, diabetic nephropathy and severe IgA nephropathy (IgAN) compared to kidneys from patients with minimal change disease (MCD) and normal kidneys (n = 5 per group for each of the six groups) ( Fig. 3j) . However, we found that HIPK2 staining in kidneys with MCD was not different from that in normal kidneys. Consistent with these findings, tubulointerstitial injury or fibrosis and glomerulosclerosis were present in HIVAN, FSGS, diabetic nephropathy and IgAN kidneys but not MCD kidneys. In both early and late stage HIVAN kidneys, HIPK2 staining in the tubulointerstitial and glomerular areas was higher than the staining of those areas in normal kidneys, but we saw less HIPK2 staining in the glomerular area compared to the tubulointerstitial area of the HIVAN kidneys. Glomerular HIPK2 expression was significantly higher in diabetic nephropathy and IgAN kidneys compared to HIVAN kidneys. HIPK2 staining in FSGS kidneys was higher than normal kidneys and was focal in its distribution. SIAH1 staining was lower in the tubules of diseased kidneys than in those of normal kidneys and was inversely related to the intensity of HIPK2 staining in all groups (Fig. 3j ). This inverse relationship between HIPK2 staining and SIAH1 staining was clear in the tubular areas but not in the glomerular areas of FSGS and HIVAN kidneys. In late stage HIVAN glomeruli, HIPK2 staining was lower compared to early stage HIVAN glomeruli, but SIAH1 staining was similar between late and early stage HIVAN glomeruli, suggesting that HIPK2 may be regulated by mechanisms that are independent of SIAH1 in late stage HIVAN glomeruli. A semi-quantitative scoring of the immunostaining data is summarized in Supplementary Table 3 .
HIPK2 mediates apoptosis and expression of EMT markers
Because RTEC apoptosis is a hallmark of tubulointerstitial injury in HIVAN and HIPK2 is known to mediate apoptosis, we sought to determine the role of HIPK2 in the HIV-induced apoptosis of RTECs. Overexpression of KD-HIPK2 in hRTECs significantly attenuated HIV-induced apoptosis (Fig. 4a ). In addition, KD-HIPK2 overexpression or siRNA-mediated knockdown of HIPK2 abrogated HIVinduced caspase 3 activity ( Fig. 4b) .
As HIPK2 interacts with the TGF-β pathway, a well known mediator of the epithelial-to-mesenchymal transition (EMT) for RTECs in vitro and kidney fibrosis in vivo, we examined the effects of HIPK2 on the expression of EMT markers in hRTECs. We found that WT-HIPK2 overexpression or treatment with TGF-β induced the expression of EMT markers, but it not have this effect in cells not overexpressing WT-HIPK2 or in cells treated with TGF-β ( Fig. 4c) . Overexpression of KD-HIPK2 diminished the expression of EMT markers in cells infected with HIV or treated with TGF-β compared to cells not overexpressing KD-HIPK2 ( Fig. 4c) . EMT is characterized npg by gain of α-smooth muscle actin (α−SMA), fibroblast-specific protein 1 (FSP1), and vimentin and loss of E-cadherin. In addition, suppression of HIPK2 activity by either KD-HIPK2 overexpression or siRNA-mediated knockdown prevented TGF-β-induced expression of EMT markers ( Fig. 4c) . Overexpression of KD-HIPK2 restored the expression of E-cadherin in hRTECs treated with TGF-β or infected with HIV ( Fig. 4d) . hRTECs have reduced amounts of E-cadherin when expressing an mCherry-WT-HIPK2 fusion gene and are protected from TGF-β-induced loss of E-cadherin when expressing an mCherry-KD-HIPK2 fusion gene ( Fig. 4d) . We further confirmed the effects of HIPK2 on the expression of EMT markers using western blot (Fig. 4e,f) . We also isolated primary RTECs from HIPK2 knockout (KO) mice and WT littermates. HIV infection induced the expression of EMT markers in WT but not KO RTECs (Fig. 4g,h) .
Role of HIPK2 mediated downstream signaling pathways in hRTECs
Signaling through p53 and TGF-β are known mediators of RTEC apoptosis [13] [14] [15] . We found that signaling components of the p53 and TGF-β pathways were among the 14 HIPK2 substrates that were enriched in our subnetwork of protein-protein interactions. Therefore, we sought to determine whether HIPK2 mediated HIV-induced activation of these pathways in hRTECs. For these studies, we used an immortalized proximal tubular epithelial cell line, HK2, because of the limited availability of primary hRTECs and the large number of cells required for these experiments. First, we confirmed that HIPK2 mediated the HIV-induced expression of EMT markers in HK2 cells ( Supplementary  Fig. 2a ). We found that KD-HIPK2 inhibited TGF-β-induced phosphorylation of Smad3 ( Fig. 5a ), suggesting that HIPK2 is required for TGF-β-induced Smad3 phosphorylation. We confirmed the interaction of HIPK2 and Smad3 using co-immunoprecipitation ( Supplementary  Fig. 2b ). Smad3 phosphorylation was enhanced by HIV infection, but this effect was abrogated by KD-HIPK2 overexpression (Fig. 5b) . HIV infection also induced p53 phosphorylation in hRTECs, which was blocked by overexpression of KD-HIPK2 ( Fig. 5c ). In addition, we found that HIV infection induced the expression of known target genes of the Wnt-β-catenin and Notch pathways, which was then blocked by overexpression of KD-HIPK2 ( Fig. 5d,e ).
HIPK2 is known to upregulate Wnt-mediated transcription by phosphorylating transcription factor 3 (TCF3), a transcriptional repressor, but to inhibit Wnt-mediated transcription by phosphorylating lymphoid enhancer-binding factor 1 (LEF1), a transcriptional activator 28 . Consistent with this, we found that WT-HIPK2 overexpression increased TCF3 phosphorylation, but not LEF1 phosphorylation, in hRTECs ( Supplementary Fig. 2c) . These results show that HIPK2 mediates the HIV-induced activation of the p53, TGF-β and Wnt-Notch pathways in RTECs.
To identify additional downstream HIPK2-mediated signaling pathways, we profiled the protein-DNA interactions and patterns of npg gene expression in human embryonic kidney cells with HIPK2 overexpression (HEK293 cells). We chose the human embryonic kidney cell line for its high efficiency of transfection. Fourteen transcription factors were upregulated and 15 transcription factors were downregulated by HIPK2 overexpression in the protein-DNA interaction arrays ( Supplementary Table 4 ). Of the upregulated interactions, nuclear factor-κB (NF-κB) and signal transducer and activator of transcription 3 (Stat3) are known to be activated in the Tg26 kidney. We also identified p53 and a downstream nuclear mediator of the TGF-β pathway, Smad3, as upregulated transcription factors. Furthermore, Snail 29 and v-ets erythroblastosis virus E26 oncogene homolog 1 (Ets1) 30 -two transcription factors known to mediate kidney fibrosiswere also upregulated. A promoter analysis of differentially expressed genes in the microarrays identified an enrichment of NF-κB and Stat3 target genes ( Supplementary Table 5 ). To confirm that NF-κB is a key transcription factor downstream of HIPK2, we examined NF-κB activation using a luciferase reporter assay. In hRTECs, KD-HIPK2 overexpression suppressed tumor necrosis factor α (TNF-α)-induced activation of NF-κB (treatment with TNF-α compared to no treatment, 10.32 ± 1.22 fold increase in relative luminescence unit (mean ± s.d.); treatment with TNF-α and KD-HIPK2 overexpression compared to no treatment and KD-HIPK2 overexpression, 2.41 ± 0.65 fold change in relative luminescence unit; n = 4 for all groups; P < 0.01 for TNF-α-treated cells compared to cells treated with TNF-α and KD-HIPK2 overexpression). We also confirmed that KD-HIPK2 overexpression inhibited, whereas 
npg
WT-HIPK2 overexpression induced, the expression of NF-κB-targeted genes in HIV-infected hRTECs (Supplementary Fig. 2d ). A pathway analysis of genes upregulated by HIPK2 using WikiPathways 31 showed that the TGF-β-receptor and Wnt-signaling pathways were both highly ranked ( Supplementary Table 5 ). These unbiased analyses confirmed that the TGF-β-Smad3, Wnt, p53 and NF-κB pathways are key pathways downstream of HIPK2.
Knockout of HIPK2 attenuates kidney fibrosis in Tg26 mice
We identified HIPK2 as a key regulator of RTEC apoptosis and expression of EMT markers in vitro. However, debate exists within the field as to whether the EMT of RTECs in vitro correlates with renal fibrosis in vivo 32 . To verify the in vivo role of HIPK2, we generated knockouttransgenic hybrid mice that were knocked out for HIPK2 and expressed the HIV transgene (KO-Tg26 mice). KO mice have no obvious renal phenotype 33, 34 . Tg26 mice typically develop proteinuria starting at 4 weeks of age. KO-Tg26 mice had lower amounts of proteinuria compared to Tg26 mice (Fig. 6a) . KO-Tg26 mice had lower concentrations of serum urea nitrogen, which is a marker of renal function, compared to Tg26 mice (Fig. 6b) . Tubulointerstitial injury and fibrosis were also significantly attenuated in KO-Tg26 mice compared to Tg26 mice (Fig. 6c,d and Supplementary Table 6) . We confirmed the reduction in renal fibrosis in KO-Tg26 mice by measurements of the collagen content within the renal cortices of the mice (Fig. 6e) . Podocyte hyperplasia and glomerulosclerosis were also lower in KO-Tg26 compared to Tg26 mice (Supplementary Table 6 ). The expression of EMT markers was significantly higher in the kidney cortices of Tg26 mice, but not KO-Tg26 mice, compared to WT mice (Fig. 6f,g and Supplementary Fig. 2e) . The expression of genes targeted by Wnt-Notch ( Fig. 6f) and NF-κB ( Fig. 6h) was higher in the kidney cortices of Tg26 compared to KO-Tg26 mice. Phosphorylation of p53, Smad3 and NFkB was also higher in the kidneys of Tg26 compared to KO-Tg26 mice (Fig. 6g) . We confirmed the greater amount of nuclear staining of β-catenin, which is a marker of EMT 35 , and phosphorylated Smad3 in the kidneys of Tg26 compared to KO-Tg26 mice (Supplementary Fig. 2e) .
Together, these findings show that knockout of HIPK2 abolished the HIV-induced activation of the p53, TGF-β-Smad3 and Wnt-Notch pathways in the kidney cortices of Tg26 mice. We also confirmed that expression of the HIV nef gene was not lower in KO-Tg26 mice than in Tg26 mice (data not shown) to ensure that reduction of HIPK2 expression did not interfere with HIV viral gene expression as a confounding experimental factor.
HIPK2 in HIV-induced podocyte de-differentiation and EMT
As HIPK2 protein expression is higher in the glomeruli of Tg26 mice than WT mice, and as KO-Tg26 mice had lower proteinuria, podocyte hyperplasia, and glomerulosclerosis than Tg26 mice, we sought to determine the role of HIPK2 in HIV-induced podocyte dedifferentiation and EMT. Glomerular expression of EMT markers was higher and glomerular expression of podocyte differentiation markers was lower in Tg26 mice, but not KO-Tg26 mice, compared to WT mice (Supplementary Fig. 3a-c) . The glomerular expression of genes targeted by Wnt-Notch and NF-κB was enhanced in Tg26 mice, but not KO-Tg26 mice, compared to WT mice (Supplementary Fig. 3d,e) . HIPK2 expression was the same in all groups of mice ( Supplementary  Fig. 3d ). Smad3 phosphorylation was greater in Tg26 compared KO-Tg26 glomeruli (Supplementary Fig. 3f ). We also confirmed that npg KD-HIPK2 overexpression suppressed the expression of desmin and Snail1, restored the expression of nephrin and the tight junction protein ZO-1, inhibited the HIV-induced expression of Wnt-Notch-and NF-κB-targeted genes and attenuated HIV-induced Smad3 phosphorylation in podocytes (Supplementary Fig. 3g-j) . These data validated the role of HIPK2 in the HIV-induced activation of profibrotic pathways in podocytes.
Oxidant stress and the expression of SIAH1 and HIPK2
Because our in vitro studies showed that inhibition of ROS by NAC restored the expression of SIAH1 and suppressed HIPK2 expression in HIV-infected RTECs, we investigated the cellular effects of NAC treatment on HIV-infected hRTECs. NAC treatment attenuated the HIV-induced increase in caspase 3 activity and EMT-marker expression ( Supplementary Fig. 4a,b) . Treatment of Tg26 mice with NAC partially attenuated the proteinuria, serum urea nitrogen elevation and kidney fibrosis in these mice (Supplementary Fig. 4c-f) . Using western blot, we confirmed that NAC treatment increased the amount of SIAH1, suppressed the amount of HIPK2 and increased the ratio of reduced to oxidized glutathione in the renal cortices of Tg26 mice compared to those of vehicle-treated Tg26 mice (Supplementary Fig. 4g,h) . These findings confirmed that reactive oxygen species (ROS) mediate HIV-induced HIPK2 expression and kidney fibrosis in Tg26 mice.
Role of HIPK2 in other models of renal fibrosis
Because our in vitro studies suggested that HIPK2 mediates the TGF-βinduced expression of EMT markers in RTECs, we hypothesized that HIPK2 might have a more general role in renal fibrosis. We tested this hypothesis in a well established model of renal fibrosis: unilateral ureteral obstruction (UUO). We found that HIPK2 was higher in npg the tubulointerstitium of WT kidneys with UUO compared to the sham-operated WT kidneys, sham-operated KO-HIPK2 kidneys and UUO KO-HIPK2 kidneys (Supplementary Fig. 5a ). UUO increased fibrosis in WT but not KO-HIPK2 kidneys, as confirmed by both Masson Trichrome and picrosirius red staining (Supplementary Fig. 5a ). SIAH1 expression was lower and HIPK2 expression was higher in WT-UUO kidneys than WT sham-operated kidneys ( Supplementary  Fig. 5b) . We confirmed renal fibrosis using quantification of the morphometric measurements of picrosirius red staining and collagen content in the renal cortices of all four groups of mice ( Supplementary  Fig. 5c ). Renal expression of the EMT markers ( Supplementary  Fig. 5d,e ), as well as nuclear β-catenin and phosphorylated Smad3 staining (Supplementary Fig. 5f ), were higher in WT-UUO kidneys, but not KO-UUO kidneys, compared to WT sham-operated kidneys. We further confirmed Smad3 phosphorylation in all four groups of mice by western blot analysis (Supplementary Fig. 5g ). We also examined the expression of Wnt-Notch target genes, which were upregulated in WT-UUO mice, but not KO-UUO mice, compared to WT sham-operated mice (Supplementary Fig. 5h) . These data indicate that HIPK2 knockout in vivo prevents tubulointerstitial fibrosis and the expression of EMT markers in the UUO model. We also examined the role of HIPK2 in a third model of renal fibrosis: folic-acid-induced renal fibrosis [36] [37] [38] . We found that KO-HIPK2 mice are protected from folic-acid-induced kidney fibrosis, as shown by renal histology and measurements of kidney hydroxylproline content ( Supplementary Fig. 6a,b) . Serum urea nitrogen concentrations and the renal expression of EMT markers were similarly reduced in KO mice treated with folic acid compared to WT mice treated with folic acid (Supplementary Fig. 6c,d) .
DISCUSSION
In this study, we integrated experimental and computational approaches to identify protein kinases responsible for the observed gene regulation changes in a disease state. Using this approach, we identified MAPK1 (ERK2), MAPK3 (ERK1) and HIPK2 as the top three protein kinases mediating gene expression in the Tg26 kidney. We previously showed that ERK mediates HIV-induced podocyte proliferation and RTEC apoptosis 24, 39 . Here, we identified HIPK2 as a key regulator of EMT in vitro and kidney fibrosis in vivo. Our data suggest that both ERK and HIPK2 are crucial for HIV-induced kidney disease. Further studies will be required to determine what crosstalk takes place between the ERK and HIPK2 pathways.
We confirmed that HIPK2 expression is higher not only in kidneys of Tg26 mice and patients with HIVAN but also in kidneys of patients with FSGS, diabetic nephropathy and IgAN. This supports a more general role for HIPK2 in human kidney diseases, which was corroborated by the fact that HIPK2 mediates renal fibrosis in three established mouse models of renal fibrosis (Tg26, UUO and folicacid-induced renal fibrosis).
We found that HIPK2 mediates HIV-induced apoptosis and the expression of EMT markers in cultured hRTECs. Apoptosis and EMT of RTECs leading to renal fibrosis have been described in many kidney diseases, including HIVAN [40] [41] [42] [43] . Recent studies have suggested that complete EMT of RTECs may not occur in vivo. However, RTECs can gain EMT markers (epithelial plasticity in fibrogenesis) after injury 44, 45 . Our data suggest that HIPK2 mediates expression of EMT markers in RTECs both in vitro and in vivo.
Our data indicate that HIPK2 expression is increased in the RTECs as well as in the glomeruli of diseased kidneys. It is possible that fibroblasts, pericytes or both also express HIPK2. We found that HIPK2 mediates the HIV-induced de-differentiation of podocytes and the expression of EMT markers in RTECs. Consistent with this, knockout of HIPK2 markedly reduced proteinuria, podocyte hyperplasia and glomerulosclerosis in Tg26 mice. Future studies will be needed to determine whether HIPK2 is required for the activation of fibroblasts, pericytes or both or whether HIPK2 mediates RTECfibroblast crosstalk.
In this study, we focused on the intracellular mechanisms of HIPK2 regulation in diseased kidneys. We found that infection with HIV decreases SIAH1 expression through DNA damage and oxidative stress, leading to the accumulation of HIPK2. In addition, we confirmed that inhibition of ROS by NAC restores SIAH1 expression, reduces HIPK2 protein concentrations and attenuates kidney injury and fibrosis in Tg26 mice. Although the renal protective effects of NAC in human kidney disease remain unresolved 46 , our data indicate that anti-ROS therapy could be a potential approach to treat patients with kidney fibrosis. Our findings are consistent with prior studies reporting that polyubiquitination promotes HIPK2 degradation 47 and that DNA damage and oxidative stress activate HIPK2 (ref. 48) .
We confirmed that HIPK2 mediates TGF-β-induced and HIVinduced pro-apoptotic and pro-fibrotic pathways in RTECs, including the p53, Smad3 and Notch-Wnt pathways. Previous studies showed that HIPK2 can either repress or promote transcriptional activation mediated by Wnt-β-catenin 9, 34 . Consistent with this, recent studies suggested that HIPK2 could affect the Wnt pathway in a contextdependent manner 28 . HIPK2 upregulates Wnt-mediated transcription by phosphorylating TCF3, a transcriptional repressor, but inhibits Wnt-mediated transcription by phosphorylating LEF1, a transcriptional activator 28 . Consistent with this, we found that overexpression of WT-HIPK2 increases TCF3 phosphorylation, but not LEF1 phosphorylation, in RTECs. NF-κB-mediated inflammation is known to cause tissue injury and fibrosis. Our studies also suggest that HIPK2 is a key regulator of the NF-κB pathway, which is a new finding that has not been previously explored, to our knowledge. These findings, summarized in Figure 6i , show that signals from initial insults, such as DNA damage or oxidative stress, increase HIPK2 expression to activate multiple signaling pathways that are involved in kidney fibrosis.
In conclusion, we present here a systems approach to identifying upstream protein kinases based on genome-wide mRNA expression microarrays and DNA-protein arrays. We identified and confirmed that HIPK2, a protein kinase previously unrecognized in kidney disease, has a crucial role in renal fibrosis. We elucidated the regulation of HIPK2 in kidney disease and in downstream signaling pathways that mediate HIPK2-induced apoptosis, as well as the expression of EMT markers in kidney cells. We believe that HIPK2 could be a new therapeutic target for kidney disease, especially as protein kinases are 'drugable' targets.
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